APA (7th ed.) Citation

AN, A., MS, A., YM, A., AB, A., HA, A. D., EM, E., . . . AA, E. (2025). Nanoliposome-mediated delivery of sulforaphane suppresses Ehrlich ascites carcinoma growth and improves liver integrity and therapeutic outcomes in a murine model. BMC cancer, 25(1), 1838. https://doi.org/10.1186/s12885-025-15279-2

Chicago Style (17th ed.) Citation

AN, Alshammari, Alfawaz MS, Alenezi YM, Al-Ghafari AB, Al Doghaither HA, Elmorsy EM, Atta MMF, and El-Raghi AA. "Nanoliposome-mediated Delivery of Sulforaphane Suppresses Ehrlich Ascites Carcinoma Growth and Improves Liver Integrity and Therapeutic Outcomes in a Murine Model." BMC Cancer 25, no. 1 (2025): 1838. https://doi.org/10.1186/s12885-025-15279-2.

MLA (9th ed.) Citation

AN, Alshammari, et al. "Nanoliposome-mediated Delivery of Sulforaphane Suppresses Ehrlich Ascites Carcinoma Growth and Improves Liver Integrity and Therapeutic Outcomes in a Murine Model." BMC Cancer, vol. 25, no. 1, 2025, p. 1838, https://doi.org/10.1186/s12885-025-15279-2.